Your browser doesn't support javascript.
loading
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis.
Koppikar, Priya; Abdel-Wahab, Omar; Hedvat, Cyrus; Marubayashi, Sachie; Patel, Jay; Goel, Aviva; Kucine, Nicole; Gardner, Jeffrey R; Combs, Andrew P; Vaddi, Kris; Haley, Patrick J; Burn, Timothy C; Rupar, Mark; Bromberg, Jacqueline F; Heaney, Mark L; de Stanchina, Elisa; Fridman, Jordan S; Levine, Ross L.
Affiliation
  • Koppikar P; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Blood ; 115(14): 2919-27, 2010 Apr 08.
Article in En | MEDLINE | ID: mdl-20154217
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytosis / Hematologic Neoplasms / Mutation, Missense / Protein Kinase Inhibitors / Janus Kinase 2 / Receptors, Thrombopoietin / Primary Myelofibrosis Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Blood Year: 2010 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytosis / Hematologic Neoplasms / Mutation, Missense / Protein Kinase Inhibitors / Janus Kinase 2 / Receptors, Thrombopoietin / Primary Myelofibrosis Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Blood Year: 2010 Document type: Article Affiliation country: Country of publication: